Revolution Medicines, Inc.
DE ˙ DB ˙ US76155X1000
135,15 € ↑0,10 (0,07%)
2026-06-05
DEL PRIS
SecurityDE:42Z / Revolution Medicines, Inc.
InstitutionTd Asset Management Inc
Latest Disclosed Ownership317,811 shares
Latest Disclosed Value $ 30,907,120
Td Asset Management Inc reports 14.23% decrease in ownership of 42Z / Revolution Medicines, Inc.

On May 11, 2026 - Td Asset Management Inc filed a 13F-HR form disclosing ownership of 317,811 shares of Revolution Medicines, Inc. (DE:42Z) valued at $26,060,502 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 370,520 shares of Revolution Medicines, Inc.. This represents a change in shares of -14.23% during the quarter. The current value of the position is $42,952,157 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F REVOLUTION MEDICINES COM 76155X100 317,811 -52,709 -14.23 30,907 4.73 0.0251
2026-02-10 2025-12-31 13F REVOLUTION MEDICINES COM 76155X100 370,520 -165,084 -30.82 29,512 17.99 0.0237
2025-11-10 2025-09-30 13F REVOLUTION MEDICINES COM 76155X100 535,604 28,004 5.52 25,013 33.94 0.0203
2025-07-28 2025-06-30 13F REVOLUTION MEDICINES COM 76155X100 507,600 181,724 55.76 18,675 62.07 0.0159
2025-05-07 2025-03-31 13F REVOLUTION MEDICINES COM 76155X100 325,876 44,490 15.81 11,523 -6.38 0.0106
2025-02-11 2024-12-31 13F REVOLUTION MEDICINES COM 76155X100 281,386 37,852 15.54 12,308 14.42 0.0109
2024-11-01 2024-09-30 13F REVOLUTION MEDICINES COM 76155X100 243,534 -6,660 -2.66 10,757 10.77 0.0095
2024-08-02 2024-06-30 13F REVOLUTION MEDICINES COM 76155X100 250,194 -4,400 -1.73 9,710 18.34 0.0091
2024-05-08 2024-03-31 13F REVOLUTION MEDICINES COM 76155X100 254,594 -17,166 -6.32 8,206 5.27 0.0076
2024-02-12 2023-12-31 13F REVOLUTION MEDICINES COM 76155X100 271,760 -64 -0.02 7,794 3.59 0.0077
2023-10-27 2023-09-30 13F REVOLUTION MEDICINES COM 76155X100 271,824 140,012 106.22 7,524 113.45 0.0091
2023-08-09 2023-06-30 13F REVOLUTION MEDICINES COM 76155X100 131,812 -2,700 -2.01 3,526 21.01 0.0040
2023-05-10 2023-03-31 13F REVOLUTION MEDICINES COM 76155X100 134,512 40,339 42.83 2,914 29.87 0.0035
2023-02-07 2022-12-31 13F REVOLUTION MEDICINES COM 76155X100 94,173 0 0.00 2,243 21.84 0.0028
2022-11-07 2022-09-30 13F REVOLUTION MEDICINES COM 76155X100 94,173 13,876 17.28 1,841 17.64 0.0023
2022-08-04 2022-06-30 13F REVOLUTION MEDICINES COM 76155X100 80,297 -8,103 -9.17 1,565 -30.60 0.0018
2022-05-10 2022-03-31 13F REVOLUTION MEDICINES COM 76155X100 88,400 15,400 21.10 2,255 22.75 0.0013
2022-02-10 2021-12-31 13F REVOLUTION MEDICINES COM 76155X100 73,000 0 0.00 1,837 -8.52 0.0015
2021-11-09 2021-09-30 13F REVOLUTION MEDICINES COM 76155X100 73,000 44,600 157.04 2,008 146.99 0.0021
2021-08-11 2021-06-30 13F REVOLUTION MEDICINES COM 76155X100 28,400 28,400 813 0.0008
2020-11-10 2020-09-30 13F REVOLUTION MEDICINES COM 76155X100 0 -9,370 -100.00 0 -100.00
2020-08-13 2020-06-30 13F REVOLUTION MEDICINES COM 76155X100 9,370 0 0.00 296 44.39 0.0004
2020-05-15 2020-03-31 13F REVOLUTION MEDICINES COM 76155X100 9,370 9,370 205 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.